eye treatment biosimilar

South Korea’s SK Biopharmaceuticals Co. is aiming to triple its enterprise value to $15 billion by 2026 with the goal of rising to the top run...

Korea Investment Corporation (KIC) saw the net value of its traditional assets rise 8.25% in the first half of this year, backed by the strong perfo...

South Korea's biopharmaceutical company Samsung Bioepis, which was expected to struggle on the US market for biosimilars of Humira, the world's top-...

South Korea’s initial public offering market is heating up with some 30 firms set for new share subscriptions in July and August, more than su...

South Korea's Daewoong Pharmaceutical said on Thursday that its local loyalty program for Nabota (American name: Jeuveau) in the US, a botulinum tox...

South Korea's Hanwha Systems Co. on Tuesday announced completion of its registration the day before as a facility-based communications operator with...

SK Hynix Inc. is in talks with its affiliate SK REIT Co. to sell the wastewater treatment facilities within its semiconductor campus in Icheon, Gyeo...

South Korean bio-health company HK inno.N Corporation's new drug for gastroesophageal reflux disease (GERD) K-CAB has been officially launched in In...

South Korea's largest trading company POSCO International revealed on Friday its strategy to establish a green hydrogen supply infrastructure with...

South Korean biopharmaceutical company Celltrion Healthcare on Monday said it launched the day before on the US market Yuflyma, a biosimilar of the ...

Air Premia Inc., a South Korean low-cost carrier, will be jointly managed by two Seoul-based private equity firms – JC Partners and AP Holding...

South Korea's largest trading company POSCO International on Sunday said it officially declared its goal of achieving carbon neutrality by 2050 to b...

South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...

South Korea’s SK E&S Co. is seeking to split up its business to raise up to 2 trillion won ($1.5 billion), according to people with knowle...

South Korea’s top auto parts maker Hyundai Mobis Co. said on Tuesday it expects to begin mass production of its rollable vehicle display &ndas...

South Korea's SK Chemicals has joined forces with global pharmaceutical firm AstraZeneca to initiate commercial production of a chemical drug for di...

South Korea’s Celltrion Inc. has put its Japanese Takeda Pharmaceutical Co.'s primary care assets acquired in 2020 on sale as the biosimilar g...

South Korea's Daehwa Pharm Co. is speeding up its advance into the Chinese market for anti-dementia medicine, applying for sales approval of its pat...

SEONGNAM, Gyeonggi Province -- POSCO DX Co., the IT services subsidiary of South Korea’s largest steelmaker POSCO Group, aims to enter the rob...

South Korea’s SK Biopharmaceuticals Co. has obtained the sales approval for its antiepileptic treatment Cenobamate in Canada, paving the way f...

South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...

South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...

FRANKFURT – Samsung Bioepis Co., a biopharmaceutical unit of South Korea’s top conglomerate Samsung, is looking to gain ground in the ra...

Sam Altman, chief executive of Microsoft-backed OpenAI and ChatGPT creator, said on Friday that he hopes to collaborate with South Korean developers...

LG Electronics Inc. will seek out new business opportunities as a premium brand in Saudi Arabia for the oil-rich kingdom’s $500 billion Neom m...

BOSTON – Samsung Biologics Co., the world’s No. 1 contract drugmaker, plans to more than double its total annual production capacity to ...

South Korea's biopharmaceutical company Celltrion Inc. announced on Monday that it has signed a contract with the US biotech firm Rani Therapeutics ...

MILAN – South Korea's biopharmaceutical company Celltrion Inc. is known in Europe for its biosimilar products such as autoimmune disease treat...

SK Networks Co., a South Korean trading company, is seeking to form a partnership with Silicon Valley-based venture capital firm Bow Capital to dive...

South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...